Effects of L-arginine and L-citrulline Supplementation on Muscle Respiration

NCT ID: NCT03998800

Last Updated: 2022-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-01

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this trial is to determine the effects of dietary supplementation with the amino acids, L-arginine and L-citrulline, on endurance performance and mitochondrial respiration in healthy men compared to supplementation with L-arginine alone and a placebo supplement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomized, double-blind, cross over trial of L-arginine and L-citrulline supplementation, L-arginine supplementation alone and placebo supplementation in healthy men. The intervention period will be 8-11 weeks for each participant and a minimum of 15 individuals will be recruited and enrolled to complete the trial. Subjects will complete the experimental protocol described below over 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks. Subjects will ingest corn-starch as a placebo, L-arginine (3g/day) or L-arginine (1.5 g/day) + L-citrulline (1.5g/day). On day 7 of the supplementation period, a skeletal muscle biopsy and blood sample will be obtained from the subjects to investigate mitochondrial function and blood amino acid and nitric oxide levels. On day 10 of the supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance. These assessments will be performed to determine the effects of co-ingesting L-arginine and L-citrulline compared to L-arginine alone and placebo administration.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dietary Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator)
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

L-arginine and L-citrulline

10 days of supplementation with 1.5 g of L-arginine and 1.5 g of L-citrulline per day

Group Type EXPERIMENTAL

Dietary Supplement

Intervention Type DIETARY_SUPPLEMENT

Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.

Endurance exercise on a cycle ergometer

Intervention Type BEHAVIORAL

On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.

L-arginine

10 days of supplementation with 3 g of L-arginine per day

Group Type EXPERIMENTAL

Dietary Supplement

Intervention Type DIETARY_SUPPLEMENT

Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.

Endurance exercise on a cycle ergometer

Intervention Type BEHAVIORAL

On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.

Placebo (corn-starch)

10 days of supplementation with corn-starch

Group Type PLACEBO_COMPARATOR

Dietary Supplement

Intervention Type DIETARY_SUPPLEMENT

Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.

Endurance exercise on a cycle ergometer

Intervention Type BEHAVIORAL

On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary Supplement

Dietary Supplement: L-arginine and L-citrulline supplement, L-arginine supplement, or placebo supplement (corn-starch) Subjects will complete 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks.

Intervention Type DIETARY_SUPPLEMENT

Endurance exercise on a cycle ergometer

On day 10 of each supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy male, 18-40 years of age
* recreationally-active
* healthy BMI (≥18.5 and ≤24.9 kg/m2)

Exclusion Criteria

* participating in other studies currently or in the past two months or has an intention to participate in other studies over the period of this study
* history of gastric, digestive, cardiovascular, renal disease or any other orthopaedic diseases related to motor organs
* lidocaine allergy
* use of medication that may affect study measures
* contraindication to the biopsy procedures
* on medications that affect the immune system
* on Aspirin or other drugs known to prolong bleeding
* smoker
* user of dietary supplements currently or in the past one month
* a heavy drinker
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kyowa Hakko Bio Co., Ltd.

INDUSTRY

Sponsor Role collaborator

Loughborough University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephen Bailey

Lecturer in Sport ad Exercise Nutrition

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen J Bailey, PhD

Role: PRINCIPAL_INVESTIGATOR

Lecturer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

School of Sport, Exercise and Health Sciences

Loughborough, Leicester, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R19-P010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.